Search Results - "Szpechcinski, Adam"

Refine Results
  1. 1

    miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives by Florczuk, Mateusz, Szpechcinski, Adam, Chorostowska-Wynimko, Joanna

    Published in Targeted oncology (01-04-2017)
    “…Lung cancer is the most common cancer worldwide. Up to 85% of lung cancer cases are diagnosed as non-small cell lung cancer (NSCLC). The effectiveness of NSCLC…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Clinical significance of TP53 alterations in advanced NSCLC patients treated with EGFR, ALK and ROS1 tyrosine kinase inhibitors: An update by Moes-Sosnowska, Joanna, Szpechcinski, Adam, Chorostowska-Wynimko, Joanna

    Published in Tumor biology (19-03-2024)
    “… The development of targeted therapies for non-small cell lung cancer (NSCLC), such as the epidermal growth factor receptor (EGFR), anaplastic lymphoma…”
    Get full text
    Journal Article
  5. 5

    Current perspectives on the use of miRNA as a biomarker for EGFR-targeted therapy for non-small cell lung cancer by Florczuk, Mateusz, Szpechciński, Adam, Chorostowska-Wynimko, Joanna

    “…Non-small cell lung cancer (NSCLC) is the leading cause of death from cancer in the world. Currently, a large number of research studies are conducted to…”
    Get full text
    Journal Article
  6. 6

    Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules by Szpechcinski, Adam, Rudzinski, Piotr, Kupis, Wlodzimierz, Langfort, Renata, Orlowski, Tadeusz, Chorostowska-Wynimko, Joanna

    Published in Cancer letters (01-05-2016)
    “…Highlights • NSCLC patients present significantly higher plasma cfDNA levels than those with benign lung tumours. • Plasma cfDNA integrity is significantly…”
    Get full text
    Journal Article
  7. 7

    Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT , ERBB2 , KRAS , and TP53 in 30% of Thymic Carcinomas by Szpechcinski, Adam, Szolkowska, Malgorzata, Winiarski, Sebastian, Lechowicz, Urszula, Wisniewski, Piotr, Knetki-Wroblewska, Magdalena

    Published in Cancers (12-07-2022)
    “…A better understanding of the molecular pathogenesis of thymic epithelial tumours (TETs) could revolutionise their treatment. We evaluated thymomas and thymic…”
    Get full text
    Journal Article
  8. 8

    Coexistence of Borrelia burgdorferi s.l. genospecies within Ixodes ricinus ticks from central and eastern Poland by Sytykiewicz, Hubert, Karbowiak, Grzegorz, Chorostowska-Wynimko, Joanna, Szpechciński, Adam, Supergan-Marwicz, Marta, Horbowicz, Marcin, Szwed, Magdalena, Czerniewicz, Paweł, Sprawka, Iwona

    Published in Acta parasitologica (01-12-2015)
    “…The purpose of the study was to assess the prevalence and coinfection rates of Borrelia burgdorferi sensu lato genotypes in Ixodes ricinus (L.) ticks sampled…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in IKIT/I, IERBB2/I, IKRAS/I, and ITP53/I in 30% of Thymic Carcinomas by Szpechcinski, Adam, Szolkowska, Malgorzata, Winiarski, Sebastian, Lechowicz, Urszula, Wisniewski, Piotr, Knetki-Wroblewska, Magdalena

    Published in Cancers (12-07-2022)
    “…The biology of thymic epithelial tumours (TETs), including thymomas and thymic carcinomas, and particularly the extent of molecular dysregulation, is poorly…”
    Get full text
    Journal Article
  11. 11

    The impact of genetic markers on the diagnosis of lung cancer: a current perspective by Chorostowska-Wynimko, Joanna, Szpechcinski, Adam

    Published in Journal of thoracic oncology (01-11-2007)
    “…Lung cancer is the leading worldwide source of cancer-related death. It is acknowledged that prognosis and treatment outcomes in lung cancer might be improved…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Studies of hepatocyte growth factor in bronchoalveolar lavage fluid in chronic interstitial lung diseases by Przybylski, Grzegorz, Chorostowska-Wynimko, Joanna, Dyczek, Andrzej, Wędrowska, Ewelina, Jankowski, Marek, Szpechciński, Adam, Giżycka, Agata, Golińska, Joanna, Kopiński, Piotr

    Published in Polskie archiwum medycyny wewne̦trznej (01-01-2015)
    “… Previous studies have suggested that hepatocyte growth factor (HGF) inhibits lung fibrosis as an antagonist of transforming growth factor β (TGF‑β).  We…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16

    Quantitative analysis of free-circulating DNA in plasma of patients with resectable NSCLC by Szpechcinski, Adam, Chorostowska-Wynimko, Joanna, Kupis, Wlodzimierz, Maszkowska-Kopij, Krystyna, Dancewicz, Maciej, Kowalewski, Janusz, Orlowski, Tadeusz

    Published in Expert opinion on biological therapy (01-06-2012)
    “…Minute amounts of free-circulating DNA are present in plasma of healthy individuals, whereas its increased concentration was observed in patients with…”
    Get more information
    Journal Article
  17. 17

    Reliable detection of rare mutations in EGFR gene codon L858 by PNA-LNA PCR clamp in non-small cell lung cancer by Skronski, Michal, Chorostowska-Wynimko, Joanna, Szczepulska, Ewa, Szpechcinski, Adam, Rudzinski, Piotr, Orlowski, Tadeusz, Langfort, Renata

    “…PNA-LNA PCR clamp real-time PCR method represents allele-specific approach to mutation analysis of EGFR gene in NSCLC. Due to its unique design, it is…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20